NRC Health Share-based Payment Arrangement, Expense, Tax Benefit
NRC Health (NRC) reported Share-based Payment Arrangement, Expense, Tax Benefit of $262.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-05-06
- NRC Health share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $262.00K, a 509.30% increase year-over-year.
- NRC Health share-based payment arrangement, expense, tax benefit for the quarter ending 2025-03-31 was $43.00K.
- NRC Health share-based payment arrangement, expense, tax benefit for fiscal 2025 was $282.00K, a 5.22% increase from fiscal 2024.
- NRC Health share-based payment arrangement, expense, tax benefit for fiscal 2024 was $268.00K, a 56.56% decline from fiscal 2023.
- NRC Health share-based payment arrangement, expense, tax benefit for fiscal 2023 was $617.00K, a 41.51% increase from fiscal 2022.
- NRC Health share-based payment arrangement, expense, tax benefit for fiscal 2022 was $436.00K, a 52.56% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|
| 2026-03-31 | $262.00K 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $282.00K 10-K · filed 2026-03-05 | ||
| 2025-03-31 | $43.00K 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $268.00K 10-K · filed 2026-03-05 | ||
| 2023-12-31 | $617.00K 10-K · filed 2026-03-05 | ||
| 2022-12-31 | $436.00K 10-K · filed 2025-03-17 | ||
| 2021-12-31 | $919.00K 10-K · filed 2024-02-27 | ||
| 2020-12-31 | $6.76M 10-K · filed 2023-03-03 | ||
| 2019-12-31 | $2.08M 10-K · filed 2022-03-04 | ||
| 2018-12-31 | $3.57M 10-K · filed 2021-03-05 | ||
| 2017-12-31 | $2.31M 10-K · filed 2020-03-06 | ||
| 2016-12-31 | $1.16M 10-K · filed 2019-03-08 | $704.00K 10-K · filed 2017-03-03 | |
| 2015-12-31 | $505.00K 10-K · filed 2018-03-14 | ||
| 2014-12-31 | $269.00K 10-K · filed 2017-03-03 | ||
| 2013-12-31 | $377.00K 10-K · filed 2016-03-04 | ||
| 2012-12-31 | $153.00K 10-K · filed 2015-03-04 | ||
| 2011-12-31 | $302.00K 10-K · filed 2014-03-04 | ||
| 2010-12-31 | $309.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |